Expression and clinicopathologic significance of HER2 and PD-L1 in high grade urothelial carcinoma of the urinary tract
International Journal of Clinical and Experimental Pathology · 2024 · 17 (8) · 236-244
DOI: 10.62347/aapb6946 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical and Experimental Pathology, 2024. Verfasst von Peizi Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai New York, NY, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai New York, NY, USA.
- Department of Pathology, Mount Sinai West New York, NY, USA.
- Department of Biostatistics, Yale School of Public Health New Haven, CT, USA.
Zitieren
APA
Li, P., Ni, P., Haines, G. K., Si, Q., Li, X., & Baskovich, B. (2024). Expression and clinicopathologic significance of HER2 and PD-L1 in high grade urothelial carcinoma of the urinary tract. International Journal of Clinical and Experimental Pathology, 17(8), 236-244. https://doi.org/10.62347/aapb6946
Vancouver
Li P, Ni P, Haines GK, Si Q, Li X, Baskovich B. Expression and clinicopathologic significance of HER2 and PD-L1 in high grade urothelial carcinoma of the urinary tract. International Journal of Clinical and Experimental Pathology. 2024;17(8):236-244. doi:10.62347/aapb6946
BibTeX
@article{Li2024,
author = {Li, Peizi and Ni, Pu and Haines, G Kenneth and Si, Qiusheng and Li, Xuanyou and Baskovich, Brett},
title = {Expression and clinicopathologic significance of HER2 and PD-L1 in high grade urothelial carcinoma of the urinary tract},
journal = {International Journal of Clinical and Experimental Pathology},
year = {2024},
volume = {17},
number = {8},
pages = {236--244},
doi = {10.62347/aapb6946}
}
EUVIMED